New injection could transform life for hemophilia patients by preventing dangerous bleeds
NCT ID NCT06569108
Summary
This study is testing whether a new injection called KN057 can safely prevent bleeding episodes in people with hemophilia A or B. The trial involves 125 male participants aged 12-70 who currently experience frequent bleeds. Researchers will compare how often bleeds occur with KN057 versus current standard treatments over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A WITHOUT INHIBITOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, 300020, China
Conditions
Explore the condition pages connected to this study.